Webb, M. (2026). The COVID-19 Dexamethasone Programme as a Real-World Validation of the Corticosteroid-Strongyloides Hyperinfection Risk. Zenodo.
Citazione stile Chigago Style (17a edizione)Webb, Marcus. The COVID-19 Dexamethasone Programme as a Real-World Validation of the Corticosteroid-Strongyloides Hyperinfection Risk. Zenodo, 2026.
Citatione MLA (9a ed.)Webb, Marcus. The COVID-19 Dexamethasone Programme as a Real-World Validation of the Corticosteroid-Strongyloides Hyperinfection Risk. Zenodo, 2026.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.